<DOC>
	<DOCNO>NCT01580514</DOCNO>
	<brief_summary>Experimental evidence suggest exenatide , glucagon-like peptide 1 receptor analogue , significant cardiovascular protective effect various condition . The investigator examine whether conventional use exenatide time primary percutaneous coronary intervention would reduce infarct size patient ST-segment elevation myocardial infarction ( STEMI ) .</brief_summary>
	<brief_title>Myocardial Protection Exenatide AMI</brief_title>
	<detailed_description>In proof-of-concept trial , assessed effect acute-phase adjunctive exenatide therapy patient STEMI . Infarct size STEMI evaluate cardiac magnetic resonance image cardiac biomarkers compare standard treatment . LV function assess conventional speckle track echocardiography . During 6-month follow , safety/tolerability exenatide clinical outcome also assess .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Islet Amyloid Polypeptide</mesh_term>
	<criteria>age 20 79 year patient present first STsegment elevation myocardial infarction Thrombolysis Myocardial Infarction [ TIMI ] flow grade 0 ) cardiac arrest ventricular fibrillation cardiogenic shock hemodynamic instability suspicious stent thrombosis leave bundle branch block previous acute myocardial infarction previous coronary artery bypass operation significant valvular heart disease primary myocardial disease atrial fibrillation significant hepatic renal dysfunction , hypoglycaemia , diabetic ketoacidosis active infection chronic inflammatory disease malignancy woman pregnant childbearing age</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>myocardial infarction</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>exenatide</keyword>
	<keyword>reperfusion injury</keyword>
	<keyword>cardiac magnetic resonance</keyword>
</DOC>